Is biliary atresia an immune mediated disease? (English)
- New search for: Alvarez, F.
- New search for: Alvarez, F.
In:
JOURNAL OF HEPATOLOGY
;
59
, 4
;
648-650
;
2013
-
ISSN:
- Article (Journal) / Print
-
Title:Is biliary atresia an immune mediated disease?
-
Contributors:Alvarez, F. ( author )
-
Published in:JOURNAL OF HEPATOLOGY ; 59, 4 ; 648-650
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2013-01-01
-
Size:3 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 59, Issue 4
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 643
-
FocusShouval, Daniel et al. | 2013
- 646
-
Does occult HBV infection have an impact on the evolution of chronic hepatitis C?Zoulim, Fabien et al. | 2013
- 648
-
Is biliary atresia an immune mediated disease?Alvarez, Fernando et al. | 2013
- 651
-
Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: A pilot studyBladowska, J. / Zimny, A. / Knysz, B. / Małyszczak, K. / Kołtowska, A. / Szewczyk, P. / Gąsiorowski, J. / Furdal, M. / Sąsiadek, M. J. et al. | 2013
- 658
-
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis CCammà, C. / Petta, S. / Cabibbo, G. / Ruggeri, M. / Enea, M. / Bruno, R. / Capursi, V. / Gasbarrini, A. / Alberti, A. / Craxì, A. et al. | 2013
- 667
-
Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapyOgawa, E. / Furusyo, N. / Nakamuta, M. / Kajiwara, E. / Nomura, H. / Dohmen, K. / Takahashi, K. / Satoh, T. / Azuma, K. / Kawano, A. et al. | 2013
- 675
-
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis CPoynard, T. / Moussalli, J. / Munteanu, M. / Thabut, D. / Lebray, P. / Rudler, M. / Ngo, Y. / Thibault, V. / Mkada, H. / Charlotte, F. et al. | 2013
- 684
-
Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapyLavocat, Fabien / Dény, Paul / Pichoud, Christian / Al Hawajri, Nasser / Kitrinos, Kathryn / Borroto-Esoda, Katyna / Zoulim, Fabien et al. | 2013
- 696
-
Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis CSquadrito, G. / Cacciola, I. / Alibrandi, A. / Pollicino, T. / Raimondo, G. et al. | 2013
- 701
-
Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytesBrownell, J. / Wagoner, J. / Lovelace, E. S. / Thirstrup, D. / Mohar, I. / Smith, W. / Giugliano, S. / Li, K. / Crispe, I. N. / Rosen, H. R. et al. | 2013
- 709
-
Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatmentSeto, W. K. / Liu, K. / Wong, D. K. / Fung, J. / Huang, F. Y. / Hung, I. F. / Lai, C. L. / Yuen, M. F. et al. | 2013
- 717
-
Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertensionBerzigotti, Annalisa / Reverter, Enric / García-Criado, Ángeles / Abraldes, Juan G. / Cerini, Federica / García-Pagán, Juan Carlos / Bosch, Jaime et al. | 2013
- 723
-
Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosisLario, M. / Muñoz, L. / Ubeda, M. a. / Borrero, M. a. / Martínez, J. / Monserrat, J. / Díaz, D. / Álvarez-Mon, M. / Albillos, A. n. et al. | 2013
- 731
-
Impaired liver regeneration in Ldlr−/− mice is associated with an altered hepatic profile of cytokines, growth factors, and lipidsPauta, Montse / Rotllan, Noemi / Vales, Frances / Fernandez-Hernando, Ana / Allen, Ryan M. / Ford, David A. / Marí, Montserrat / Jiménez, Wladimiro / Baldán, Ángel / Morales-Ruiz, Manuel et al. | 2013
- 738
-
IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed miceWeng, H. l. / Feng, D. c. / Radaeva, S. / Kong, X. n. / Wang, L. / Liu, Y. / Li, Q. / Shen, H. / Gao, Y. p. / Müllenbach, R. et al. | 2013
- 746
-
Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing “stemness”-related markersKim, H. / Yoo, J. E. / Cho, J. Y. / Oh, B. K. / Yoon, Y. S. / Han, H. S. / Lee, H. S. / Jang, J. J. / Jeong, S. H. / Kim, J. W. et al. | 2013
- 753
-
Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinomaGolfieri, Rita / Bilbao, Josè Ignacio / Carpanese, Livio / Cianni, Roberto / Gasparini, Daniele / Ezziddin, Samer / Paprottka, Philipp Marius / Fiore, Francesco / Cappelli, Alberta / Rodriguez, Macarena et al. | 2013
- 762
-
p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 releaseYan, H. X. / Wu, H. P. / Zhang, H. L. / Ashton, C. / Tong, C. / Wu, H. / Qian, Q. J. / Wang, H. Y. / Ying, Q. L. et al. | 2013
- 769
-
Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinomaWaidmann, Oliver / Köberle, Verena / Bettinger, Dominik / Trojan, Jörg / Zeuzem, Stefan / Schultheiß, Michael / Kronenberger, Bernd / Piiper, Albrecht et al. | 2013
- 780
-
ER stress in human hepatic cells treated with Efavirenz: Mitochondria againApostolova, N. / Gomez-Sucerquia, L. J. / Alegre, F. / Funes, H. A. / Victor, V. M. / Barrachina, M. D. / Blas-Garcia, A. / Esplugues, J. V. et al. | 2013
- 790
-
Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresiaTucker, Rebecca M. / Feldman, Amy G. / Fenner, Erika K. / Mack, Cara L. et al. | 2013
- 797
-
Gender matters: Estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A)Kalthoff, S. / Winkler, A. / Freiberg, N. / Manns, M. P. / Strassburg, C. P. et al. | 2013
- 805
-
ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loadingFernandez, A. / Matias, N. r. / Fucho, R. / Ribas, V. / Von Montfort, C. / Nuño, N. / Baulies, A. / Martinez, L. / Tarrats, N. r. / Mari, M. et al. | 2013
- 814
-
Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines:Consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and NutritionSokal, E. M. / Paganelli, M. / Wirth, S. / Socha, P. / Vajro, P. / Lacaille, F. / Kelly, D. / Mieli-Vergani, G. et al. | 2013
- 814
-
Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelinesSokal, Etienne M. / Paganelli, Massimiliano / Wirth, Stefan / Socha, Piotr / Vajro, Pietro / Lacaille, Florence / Kelly, Deirdre / Mieli-Vergani, Giorgina et al. | 2013
- 830
-
Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosisFrau, M. / Feo, F. / Pascale, R. M. et al. | 2013
- 842
-
The metabolomic window into hepatobiliary diseaseBeyoğlu, D. / Idle, J. R. et al. | 2013
- 859
-
From NAFLD in clinical practice to answers from guidelinesNascimbeni, F. / Pais, R. / Bellentani, S. / Day, C. P. / Ratziu, V. / Loria, P. / Lonardo, A. et al. | 2013
- 872
-
Immunosuppression minimization vs. complete drug withdrawal in liver transplantationLondoño, Maria-Carlota / Rimola, Antoni / O’Grady, John / Sanchez-Fueyo, Alberto et al. | 2013
- 880
-
Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapyLiaw, Y. F. et al. | 2013
- 882
-
Oncolytic immunotherapeutic virus in HCC: Can it compete with molecular therapies?Hernandez-Gea, Virginia / Alsinet, Clara / Llovet, Josep M. et al. | 2013
- 885
-
ABT-450 combined with ritonavir, in addition to ABT-333 and ribavirin: A race for an interferon-free regimen to cure HCV infectionAsselah, Tarik et al. | 2013
- 889
-
Coagulopathy in cirrhosis – The role of the platelet in hemostasisTapper, Elliot B. / Robson, Simon C. / Malik, Raza et al. | 2013
- 891
-
Cannabinoid signaling and liver therapeuticsMallat, Ariane / Teixeira-Clerc, Fatima / Lotersztajn, Sophie et al. | 2013
- 897
-
Challenges in cancer vaccine development for hepatocellular carcinomaBuonaguro, L. / Petrizzo, A. / Tagliamonte, M. / Tornesello, M. L. / Buonaguro, F. M. et al. | 2013
- 904
-
Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutationWillson, J.S.B. / Godwin, T.D. / Wiggins, G.A.R. / Guilford, P.J. / McCall, J.L. et al. | 2013
- 908
-
Infliximab as rescue therapy in paediatric autoimmune hepatitisRajanayagam, Jeremy / Lewindon, Peter J. et al. | 2013
- 909
-
Flow cytometry makes all the differencePembroke, Tom / Gallimore, Awen / Godkin, Andrew et al. | 2013
- 910
-
Reply to: “Flow cytometry makes all the difference”Oliviero, Barbara / Mele, Dalila / Varchetta, Stefania / Mondelli, Mario U. et al. | 2013
- 912
-
Circulating platelet derived microparticles are not increased in patients with cirrhosisRautou, Pierre-Emmanuel / Vion, Anne-Clémence / Valla, Dominique / Boulanger, Chantal M. et al. | 2013
- 913
-
Reply to: “Circulating platelet derived microparticles are not increased in patients with cirrhosis”Tapper, Elliot B. / Robson, Simon / Malik, Raza et al. | 2013
- 914
-
Corrigendum to: “FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program” [J Hepatol 2011;54:227–235]Poynard, Thierry / Munteanu, Mona / Colombo, Massimo / Bruix, Jordi / Schiff, Eugene / Terg, Ruben / Flamm, Steven / Moreno-Otero, Ricardo / Carrilho, Flair / Schmidt, Warren et al. | 2013
- vii
-
Contents| 2013
-
IFC See you in London for the International Liver CongressTM 2014| 2013
-
Join EASL today, become part of our vision| 2013
-
EASL LiverTreeTM| 2013
-
Call for applications for the Journal of Hepatology: Editor-in-Chief 2015–2020| 2013
-
Journal of Hepatology iPad edition now available| 2013
-
Editorial Board| 2013
-
Translational Research in Chronic Viral Hepatitis: EASL Monothematic Conference, Lyon 2013| 2013
-
EASL Basic School of Hepatology, Epithelial Mesenchymal Interactions in Liver Development, Diseases and Cancer, Milan 2014| 2013
-
EASL iLiver app| 2013